03/31/2026
Melatonin for Scoliosis
Melatonin is biologically linked to spinal growth and there is emerging, but still limited, evidence that supplementation might help slow curve progression in some adolescents with idiopathic scoliosis, particularly when combined with vitamin D and calcium and when curves are mild. It is not a stand‑alone, proven treatment and should be considered adjunctive to standard orthopedic management (observation, bracing, surgery when indicated).
What is known about melatonin and AIS
- Melatonin receptors are present in bone and muscle, suggesting a role in bone growth, muscle tone, and postural control relevant to adolescent idiopathic scoliosis (AIS).�
- Animal models show that melatonin deficiency can induce scoliosis and that replacing melatonin reduces both incidence and severity of curves, and improves bone quality.�
- In humans, studies are mixed: some show reduced melatonin levels or altered rhythms in AIS, while others do not, so a simple “melatonin deficiency causes scoliosis” model is not supported.�
Human clinical data on supplementation
- A prospective study of 40 adolescents with idiopathic scoliosis found that those with low serum melatonin had more curve progression; treating low melatonin was associated with more stable curves, particularly when initial Cobb angle was under 35 degrees.�
- A randomized case‑control interventional study in children and adolescents (Risser 0–3) using melatonin 1.5 mg/day, calcium 600 mg/day, and vitamin D 2000 IU/day reported that this combination positively affected curve progression compared with controls, suggesting possible benefit as an adjunct to standard care.�
- Current reviews emphasize that evidence is preliminary; the role of melatonin in AIS pathogenesis and treatment remains uncertain and larger, high‑quality trials are needed.�
Practical considerations (juvenile/young adolescent)
- Typical studied doses in scoliosis work have been low (around 1.5 mg at night) as part of a combination regimen, not high-dose monotherapy.�
- Melatonin is generally considered safe short‑term in adolescents, but long‑term safety data, especially in very young or peripubertal children, are still limited, so dosing and duration should be overseen by the managing physician.�
- Any melatonin strategy should sit on top of, not replace, evidence‑based scoliosis management: serial radiographs, growth and Risser staging, early bracing when indicated, and timely surgical referral for large or progressive curves.�
How this might fit into a management plan
For a juvenile/young adolescent with idiopathic scoliosis, a reasonable, medically supervised approach could be:
- Confirm curve magnitude, Risser stage, and growth status, then stratify risk and follow standard orthopedic guidelines (observation vs bracing).�
- Consider baseline labs (including vitamin D and possibly melatonin, where accessible) if contemplating supplementation, recognizing melatonin testing is not standardized in routine practice.�
- Discuss with the pediatric orthopedist whether a low‑dose nighttime melatonin, plus vitamin D and calcium, is appropriate as an adjunct in a mild, growing‑spine AIS case, with clear monitoring of Cobb angle over time.
The best source of vitamins and supplements that we know of that is an American company, tried and tested, and standardied is Nutridyn. https://creekstone.nutridyn.com/all-products/index/ndcp?cat_key=Blood%20Sugar%20Balance
DISCLAIMER: This resource search was accomplished through a search of Perplexity AI to identify sources. AI can make mistakes, and you should consult with your healthcare professional before beginning treatment
https://pmc.ncbi.nlm.nih.gov/articles/PMC3087042/
https://treatingscoliosis.com/blog/melatonin-for-adolescent-idiopathic-scoliosis-key-insights/
https://www.nature.com/articles/s41598-019-42467-5
https://pubmed.ncbi.nlm.nih.gov/19317797/
https://www.scoliosisspineclinic.com.au/post/vitd-calcium-and-melatonin-added-to-standard-care-is-known-to-reduce-progression-of-scoliosis-in-gr
https://www.sciencedirect.com/science/article/abs/pii/S1479666X21001347
https://pubmed.ncbi.nlm.nih.gov/19317797/
https://pmc.ncbi.nlm.nih.gov/articles/PMC9140159/